Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, volume I.

Front Pharmacol

Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Instituto Universitario de Investigación en Neuroquímica (IUIN-UCM), Madrid, Spain.

Published: September 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523692PMC
http://dx.doi.org/10.3389/fphar.2022.1033281DOI Listing

Publication Analysis

Top Keywords

editorial neuroinflammatory
4
neuroinflammatory oxidative/nitrosative
4
oxidative/nitrosative pathways
4
pathways neuropsychiatric
4
neuropsychiatric neurological
4
neurological diseases
4
diseases neuropharmacological
4
neuropharmacological regulation
4
regulation volume
4
editorial
1

Similar Publications

Stroke is an often underrecognized albeit significant complication in patients with brain cancer, arising from the intricate interplay between cancer biology and cerebrovascular health. This review delves into the multifactorial pathophysiological framework linking brain cancer to elevated stroke risk, with particular emphasis on the crucial role of the neurotoxic microenvironment (NTME). The NTME, characterized by oxidative stress, neuroinflammation, and blood-brain barrier (BBB) disruption, creates a milieu that promotes and sustains vascular and neuronal injury.

View Article and Find Full Text PDF

Background: The occurrence of Alzheimer's disease (AD) can be partially prevented through healthy lifestyles, but the mechanisms associated with AD pathology are unclear.

Objective: To explore associations among healthy lifestyle characteristics (HLCs), cerebrospinal fluid (CSF) soluble TREM2 (sTREM2), and AD biomarkers.

Methods: From the Chinese Alzheimer's Biomarker and LifestylE (CABLE) study, 924 cognitively normal participants were enrolled in this cross-sectional analysis.

View Article and Find Full Text PDF

Background: Riluzole exhibits neuroprotective and therapeutic effects in several neurological disease models associated with excessive synaptic glutamate (Glu) release. We recently showed riluzole prevents acute excitotoxic hippocampal neural injury at 3 days in the kainic acid (KA) model of temporal lobe epilepsy (TLE). Currently, it is unknown if preventing acute neural injury and the neuroinflammatory response is sufficient to suppress epileptogenesis.

View Article and Find Full Text PDF

Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders.

Front Cell Neurosci

October 2024

Dr. Kiran C. Patel College of Osteopathic Medicine, Institute for Neuro-Immune Medicine, Nova Southeastern University, Ft. Lauderdale, FL, United States.

Article Synopsis
  • - The neurovascular unit (NVU) inflammation from glial cell activation and neuronal damage significantly contributes to neurodegenerative diseases, though the exact disease mechanisms are not fully understood.
  • - Biomarkers like neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) can indicate the severity, progression, and treatment response in various brain disorders by assessing brain cell health and blood-brain barrier integrity.
  • - Chronic inflammation is prevalent in age-related neurodegenerative diseases such as Alzheimer's and Parkinson's, and certain biomarkers may change years before disease onset, highlighting their potential for early detection and research into neurovascular pathologies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!